Domini Bryer

C‐reactive protein as a predictor of infliximab treatment outcome in patients with rheumatoid arthritis: Defining subtypes of nonresponse and subsequent response to etanercept

Maya H Buch, Yohei Seto, Sarah Bingham et al. · Arthritis & Rheumatism · 2005 · 107 citations

Medicine, Internal Medicine, Pharmacotherapy +15

Long-term infliximab treatment in rheumatoid arthritis: subsequent outcome of initial responders

Maya H Buch, Sarah Bingham, Domini Bryer et al. · Lara D. Veeken · 2007 · 101 citations

Medicine, Pharmacology, Pharmacotherapy +15

Real life experience confirms sustained response to long-term biologics and switching in ankylosing spondylitis

Laura C. Coates, Lorna Cawkwell, Nora Ng et al. · Lara D. Veeken · 2008 · 90 citations · Full text

Medicine, Pharmacotherapy, Musculoskeletal Medicine +6

Therapy of patients with rheumatoid arthritis: Outcome of infliximab failures switched to etanercept

Maya H Buch, Sarah Bingham, Victoria Bejarano et al. · Arthritis Care & Research · 2007 · 78 citations

Medicine, Pharmacology, Pharmacotherapy +15

Delay in imaging versus clinical response: A rationale for prolonged treatment with anti–tumor necrosis factor medication in early rheumatoid arthritis

Richard J. Wakefield, Jane Freeston, E. Hensor et al. · Arthritis Care & Research · 2007 · 72 citations

Medicine, Clinical Sciences, Pharmacotherapy +14